Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease
about
The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemiaTriglyceride-rich lipoproteins as a causal factor for cardiovascular diseaseHypertriglyceridemia and Cardiovascular Diseases: RevisitedMendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the futureThe year in cardiology 2015: preventionElectronegative low-density lipoprotein increases the risk of ischemic lower-extremity peripheral artery disease in uremia patients on maintenance hemodialysisPlasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.Update on the management of severe hypertriglyceridemia--focus on free fatty acid forms of omega-3.Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting State.Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.Electronegative Low-density Lipoprotein Increases Coronary Artery Disease Risk in Uremia Patients on Maintenance HemodialysisIs Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism.Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia.Dysfunctional HDL and atherosclerotic cardiovascular disease.HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology.Mendelian Randomization Analyses for Selection of Therapeutic Targets for Cardiovascular Disease Prevention: a Note of Circumspection.Hypertriglyceridaemia and risk of coronary artery disease.Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent ImplantationMOGAT2: A New Therapeutic Target for Metabolic Syndrome.Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease.Plasma lipidomics reveals potential lipid markers of major depressive disorder.Raman spectroscopy imaging reveals interplay between atherosclerosis and medial calcification in the human aorta.Hypertriglyceridemia and atherosclerosis.Association of Antituberculosis Treatment and Lower Risk of Hyperlipidemia in Taiwanese Patients: A Population-Based Case-Control Study.Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very-Low-Density Lipoproteins.Triglyceride-rich lipoprotein cholesterol (TRL-C): the ugly stepsister of LDL-C.New challenges for HDL-modifying therapies as a strategy to lower cardiovascular disease events in statin-treated patients.New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent.[Severe hypertriglyceridemia : Diagnostics and new treatment principles].Dyslipidaemia: Small triumph for fenofibrate therapy in dyslipidaemia.Association between fasting Triglyceride levels and the Prevalence of Asymptomatic Intracranial Arterial Stenosis in a Chinese Community-based Study.Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care.Adiposity and Genetic Factors in Relation to Triglycerides and Triglyceride-Rich Lipoproteins in the Women's Genome Health Study
P2860
Q26738554-AD1F0AA8-6855-46FB-AC6A-BF1D3151BD5EQ26745946-157288D3-4CA7-49E6-9F61-73D8C054B566Q26750954-8BBAF012-7CF4-4377-915D-080B71854E88Q28070061-80479D6A-0073-44A7-A38D-218BED832C31Q28072221-DCE44024-2743-4C83-A06D-3D260E080EC5Q33875661-10F75204-E66F-4135-B834-349481791D71Q34480492-CE1A8B76-6BC4-42C1-8243-BEA850B8D6DFQ35460381-02B8650C-FEA4-4AA9-83A1-54753F4EA042Q36011783-12C715B4-79FF-4D8F-8039-A9ED1286D958Q36068779-4BE8F7C9-16C1-4177-B145-AFFADBB5DBC5Q36073931-5C95AE83-2CC3-4D74-882E-739652E2F3FAQ36478016-B12E92C3-29A4-432E-A6DA-172D59E75DB2Q36913493-6A124AEF-4CB3-41AE-9BDD-8D7BFBBEF5C3Q36930209-75272E43-8566-426B-9E8B-C5AD32F9E0FFQ37034257-554A8F5F-90E8-4E48-B1D7-08A67BB4CE4FQ38577283-977CFAFA-B211-41C1-A0A6-0A5DC5C450CCQ38630971-60694920-B4FF-4F28-99CA-E8A317FC877BQ38707328-8FB3E648-F302-45AB-B063-97223DAB6B2EQ39181612-19F3903C-F86B-4442-AC3D-1C6B20B24CC7Q42267353-56C90328-C29C-43AB-A8B5-3EC22D2BC662Q42343443-AE98AF5D-FAD8-44CE-854D-EC0E6284E78CQ46033907-584213E7-3F81-425F-B99B-D2EBCD8B0937Q46511372-A9119FBA-2302-47DC-B91B-5D4F974D175CQ47118560-5233B83A-736C-4201-8084-1E2643526C32Q47180199-B9A83215-B8BB-44C8-876C-49274A7364DBQ47221266-EB6D8556-212E-4218-AB0A-91A482C6CA9DQ49736271-07F8CC93-6191-4563-A5EF-985F0AD673FDQ50001089-F2BD2E32-F88D-4563-AFC2-FCC45E44EA91Q51006174-CCA2DADF-EB58-493E-9CC0-49E4535178B8Q52584406-BFB0AB63-A860-4BB2-BEB0-0765C896AEF7Q52838993-56020E49-DCA0-403F-97A2-851D4DFF35AFQ54394383-B9AD1973-6194-4197-8964-6403E1281BAAQ55025478-BA38B34B-61F5-498C-91FC-D975269247F9Q55176268-AE6E4205-C547-432A-AD12-DE2C495DC203Q57303438-4F434978-2478-4625-8E4E-2418DA52ABE2
P2860
Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genetics and causality of trig ...... lerotic cardiovascular disease
@ast
Genetics and causality of trig ...... lerotic cardiovascular disease
@en
Genetics and causality of trig ...... lerotic cardiovascular disease
@nl
type
label
Genetics and causality of trig ...... lerotic cardiovascular disease
@ast
Genetics and causality of trig ...... lerotic cardiovascular disease
@en
Genetics and causality of trig ...... lerotic cardiovascular disease
@nl
prefLabel
Genetics and causality of trig ...... lerotic cardiovascular disease
@ast
Genetics and causality of trig ...... lerotic cardiovascular disease
@en
Genetics and causality of trig ...... lerotic cardiovascular disease
@nl
P2093
P921
P3181
P1476
Genetics and causality of trig ...... lerotic cardiovascular disease
@en
P2093
Benjamin J. Hirsh
Daniel Gaudet
Michael H. Davidson
Robert S. Rosenson
P304
P3181
P356
10.1016/J.JACC.2014.09.042
P407
P577
2014-12-16T00:00:00Z